This site is intended for US residents only.
JOURNAVX is now available at major national and select regional retail pharmacies.
If you’re considering JOURNAVX, you might have some questions. Here you’ll find information about JOURNAVX, acute pain, dosing, and other related questions.
Talk to your doctor if you have questions.
Acute pain is a type of pain that starts suddenly and lasts less than 3 months. It often happens because of an injury or surgery.
When you have an injury or surgery, your body creates pain signals that travel through your nerves to your brain. It's not until the brain receives these signals that you feel pain.
JOURNAVX is a prescription medicine used to treat adults with moderate-to-severe short-term (acute) pain.
Learn more about the results with JOURNAVX.
See the safety profile of JOURNAVX.
Learn more about the safety profile of JOURNAVX.
Learn more about the study design.
Learn more about how JOURNAVX works.
If you miss 1 dose:
If you miss 2 or more doses:
If you miss a dose and have liver problems or take moderate inhibitors of CYP3A:
If you are not sure about your dosing, ask your doctor or pharmacist.
Before taking JOURNAVX, tell your doctor about all of your medical conditions, including if you:
Tell your doctor about all the medicines you take, especially if you take hormonal birth control, medicines that are substrates of an enzyme called CYP3A, or if you have liver problems, as dosing instructions may vary.
Do not take JOURNAVX if you take certain medicines that are strong inhibitors of an enzyme called CYP3A. Ask your doctor if you're not sure.
The JOURNAVX+you Patient Support Program provides resources and support to help you get started with JOURNAVX.
JOURNAVX+you includes the following offerings:
Learn more about the Patient Support Program.
There are financial support programs available to help reduce patient out-of-pocket costs for JOURNAVX.
A JOURNAVX Savings Card is available for eligible patients. Learn more at JOURNAVX.com/support.
If you are uninsured, you may be eligible to participate in the Patient Assistance program. Visit JOURNAVXpap.com for more information.
JOURNAVX is available at major national and select regional retail pharmacies. Product availability at individual stores may vary. Please check with your preferred retail pharmacy to see if they carry JOURNAVX.
What is JOURNAVX?
JOURNAVX is a prescription medicine used to treat adults with moderate-to-severe short-term (acute) pain.
It is not known if JOURNAVX is safe and effective in children.
IMPORTANT SAFETY INFORMATION
Do not take JOURNAVX if you take certain medicines that are strong inhibitors of an enzyme called CYP3A. Ask your healthcare provider if you are not sure.
Before taking JOURNAVX, tell your healthcare provider about all of your medical conditions, including if you:
What is JOURNAVX?
JOURNAVX is a prescription medicine used to treat adults with moderate-to-severe short-term (acute) pain.
It is not known if JOURNAVX is safe and effective in children.
IMPORTANT SAFETY INFORMATION
Do not take JOURNAVX if you take certain medicines that are strong inhibitors of an enzyme called CYP3A. Ask your healthcare provider if you are not sure.
Before taking JOURNAVX, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Taking JOURNAVX with certain other medicines may affect the way JOURNAVX and the other medicines work and may increase your risk of side effects. Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure.
Especially tell your healthcare provider if you take:
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
What should I avoid while taking JOURNAVX?
Do not take food or drink containing grapefruit during treatment with JOURNAVX.
What are the possible side effects of JOURNAVX?
The most common side effects for patients treated with JOURNAVX included itching, muscle spasms, increased blood level of creatine phosphokinase, and rash.
JOURNAVX may temporarily reduce the chance of females becoming pregnant while on treatment. Talk to your healthcare provider if you have concerns about becoming pregnant. If you are using contraceptives, you should continue to use contraceptives during treatment with JOURNAVX.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all of the possible side effects of JOURNAVX.
Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Please see full Prescribing Information, including Patient Information, for JOURNAVX.